WFMPM
TEVA icon

Woodley Farra Manion Portfolio Management’s Teva Pharmaceuticals TEVA Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,395
Closed -$17K – 358
2020
Q2 		$17K Hold
1,395
– – ﹤0.01% 240
2020
Q1 		$13K Hold
1,395
– – ﹤0.01% 263
2019
Q4 		$14K Buy
+1,395
New +$12.5K ﹤0.01% 263
2017
Q2 		– Sell
-7,145
Closed -$229K – 79
2017
Q1 		$229K Sell
7,145
-3,500
-33% -$119K 0.03% 73
2016
Q4 		$386K Hold
10,645
– – 0.05% 64
2016
Q3 		$490K Hold
10,645
– – 0.07% 62
2016
Q2 		$535K Sell
10,645
-354,706
-97% -$18.9M 0.08% 63
2016
Q1 		$19.6M Sell
365,351
-2,380
-0.6% -$140K 3.24% 16
2015
Q4 		$24.1M Buy
367,731
+5,302
+1% +$328K 4.25% 5
2015
Q3 		$20.5M Buy
362,429
+2,334
+0.6% +$151K 4.09% 8
2015
Q2 		$21.3M Sell
360,095
-3,750
-1% -$231K 4.08% 7
2015
Q1 		$22.7M Buy
363,845
+820
+0.2% +$47.7K 3.95% 5
2014
Q4 		$20.9M Buy
363,025
+1,800
+0.5% +$100K 3.79% 13
2014
Q3 		$19.4M Buy
361,225
+1,434
+0.4% +$76K 3.63% 12
2014
Q2 		$18.9M Sell
359,791
-1,705
-0.5% -$87.1K 3.53% 15
2014
Q1 		$19.1M Buy
+361,496
New +$16.7M 3.78% 11

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's TEVA Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 1,395 shares — an estimated $17K sold.

Woodley Farra Manion Portfolio Management first reported a position in TEVA in Q1 2014 and held it in 16 quarters. The position peaked at $24.1M in Q4 2015. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 1,395 Teva Pharmaceuticals shares in Q3 2020, an estimated $17K.
  • Woodley Farra Manion Portfolio Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 16 quarters.
  • Woodley Farra Manion Portfolio Management's Teva Pharmaceuticals position peaked at $24.1M in Q4 2015.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.